Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer's disease 2015-09-02
  2. Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease 2006-05-01

Studies

2 studies carry this tag.

Date range

2006 to 2015

Top journals

  • Frontiers in molecular neuroscience 1
  • Journal of neuropathology and experimental neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in molecular neuroscience 2015-09-02 TREM2 and immune genetics

    Amyloid β (Aβ) plaque formation is a prominent cellular hallmark of Alzheimer's disease (AD).

  2. Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuropathology and experimental neurology 2006-05-01 Drug development

    The mitogen-activated protein (MAP) kinase SAPK/JNK phosphorylates tau protein at many of its proline-directed serine/threonine residues in vitro and is a likely candidate kinase to phosphorylate the pathologically relevant S422 site on tau.

All topic tags with their study counts